The Warren Alpert Medical School of Brown University, Division of Hematology-Oncology, Rhode Island Hospital, Providence, RI.
The Warren Alpert Medical School of Brown University, Division of General Internal Medicine, Rhode Island Hospital, Providence, RI.
R I Med J (2013). 2020 Oct 1;103(8):78-83.
Heparin-induced thrombocytopenia (HIT) remains a difficult clinical diagnosis, even with the under-utilized standardized scoring systems, like the '4T' score, to aid in clinical decision-making. Our quality improvement study sought to assess the use of '4T' score, improve the use of HIT antibody (HITA) testing and improvement management of possible HIT by implementing an in-line calculator with guidance within our electronic medical record (EMR) at our institution. We retrospectively reviewed patient charts between October 2017 and October 2018, assessing practices before and after implementation of the '4T' in-line calculator in April 2018. HITA were ordered inappropriately (for 4T <4) in 141 (67%) of 210 instances (75 before and 66 after). We found no statistically significant difference in positive predictive value (PPV) or 4T documentation in provider notes after its implementation. We were able to identify problematic areas in HIT management, such as the ordering of non-heparin anticoagulants, and implement additional changes addressing these problems.
肝素诱导的血小板减少症(HIT)仍然是一个难以诊断的临床问题,即使有未充分利用的标准化评分系统,如“4T”评分,以帮助临床决策。我们的质量改进研究旨在评估“4T”评分的使用情况,通过在我们的电子病历(EMR)中实施在线计算器并提供指导来改善 HIT 抗体(HITA)检测的使用情况,并改善可能的 HIT 的管理。我们回顾性地审查了 2017 年 10 月至 2018 年 10 月期间的患者病历,评估了 2018 年 4 月实施“4T”在线计算器前后的实践情况。在 210 例(75 例在实施前,66 例在实施后)中,有 141 例(67%)不恰当地开具了 HITA(4T<4)。我们发现实施后提供者记录中的阳性预测值(PPV)或 4T 记录没有统计学上的显著差异。我们能够确定 HIT 管理中的问题区域,例如非肝素抗凝剂的开具,并实施了其他解决这些问题的更改。